The Patent Finder

Vantia Limited

Also on record
Records under this name other than patents Vantia Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Vantia Limited

PatentTitleStatus Expires Confidence
US 11,234,939Dosage Forms Comprising a Plasma Kallikrein Inhibitor
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,649,000Selective Dipeptide Inhibitors of Kallikrein
Formerly held
Term ended
Term ended Oct 11, 2025 · High confidence
Term endedTerm ended Oct 11, 2025High confidence
US 8,202,858Vasopressin V1a antagonists
Lapsed on the fee record
Ended Jun 19, 2024 · From the USPTO record
Lapsed on the fee recordEnded Jun 19, 2024From the USPTO record
US 9,145,397Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide
Lapsed on the fee record
Ended Sep 29, 2023 · From the USPTO record
Lapsed on the fee recordEnded Sep 29, 2023From the USPTO record
US 9,079,881Polymorph of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl)benzylcarbamoyl)-L-proline-N,N-dimethylamide
Lapsed on the fee record
Ended Jul 14, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 14, 2023From the USPTO record
US 9,073,928Tosylate salt of cyclopropanecarboxylic acid 4-(6-chloro-3-methyl-4, 10-dihydro-3H-2,3,4,9-tetrabenzo[f]azulene-9-carbonyl)-2-fluorobenzylamide
Lapsed on the fee record
Ended Jul 7, 2023 · From the USPTO record
Lapsed on the fee recordEnded Jul 7, 2023From the USPTO record
US 7,074,781Condensed azepines as vasopressin agonists
Term ended
Term ended Feb 22, 2022 · From the USPTO record
Term endedTerm ended Feb 22, 2022From the USPTO record
US 7,560,454Condensed azepines as vasopressin agonists
Term ended
Term ended Jan 4, 2021 · From the USPTO record
Term endedTerm ended Jan 4, 2021From the USPTO record
US 8,183,280FAP inhibitors
Lapsed on the fee record
Ended May 22, 2016 · From the USPTO record
Lapsed on the fee recordEnded May 22, 2016From the USPTO record
US 6,096,712Kininogen inhibitors
Term ended
Term ended May 16, 2016 · From the USPTO record
Term endedTerm ended May 16, 2016From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited